|
Real-time Estimate
Tradegate
15:44:22 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 58.84 EUR | -1.57% |
|
-3.38% | -23.37% |
| 10:07am | 'Let them be scared': Moscow sends EU message with widening corporate crackdown | RE |
| 09-24 | BofA Expects Danone to Benefit from Clinical Nutrition Business Growth; Price Objective Down | MT |
Company Valuation: Danone
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 35,530 | 30,830 | 37,646 | 41,915 | 49,156 | 37,800 | - | - |
| Change | - | -13.23% | 22.11% | 11.34% | 17.28% | -23.1% | - | - |
| Enterprise Value (EV) 1 | 46,030 | 40,937 | 47,867 | 50,516 | 57,587 | 46,777 | 45,874 | 45,438 |
| Change | - | -11.06% | 16.93% | 5.53% | 14% | -18.77% | -1.93% | -0.95% |
| P/E | 18.6x | 33.3x | 45.1x | 20.8x | 27.2x | 15.8x | 14.5x | 13.6x |
| PBR | 2.02x | 1.76x | 2.33x | 2.59x | 2.93x | 2.14x | 2.04x | 1.95x |
| PEG | - | -0.7x | -3.7x | 0x | -2.75x | 0.5x | 1.54x | 2.03x |
| Capitalization / Revenue | 1.46x | 1.11x | 1.36x | 1.53x | 1.8x | 1.34x | 1.28x | 1.24x |
| EV / Revenue | 1.9x | 1.48x | 1.73x | 1.85x | 2.11x | 1.66x | 1.56x | 1.48x |
| EV / EBITDA | 10x | 7.81x | 9.4x | 10.7x | 11.5x | 9.43x | 8.74x | 8.26x |
| EV / EBIT | 13.8x | 12.1x | 13.8x | 14.2x | 15.7x | 12.2x | 11.2x | 10.5x |
| EV / FCF | 18.9x | 19.6x | 18.2x | 16.8x | 20.6x | 18.7x | 16.4x | 15.4x |
| FCF Yield | 5.28% | 5.11% | 5.5% | 5.94% | 4.86% | 5.35% | 6.1% | 6.49% |
| Dividend per Share 2 | 1.94 | 2 | 2.1 | 2.15 | 2.25 | 2.352 | 2.501 | 2.664 |
| Rate of return | 3.55% | 4.06% | 3.58% | 3.3% | 2.93% | 3.95% | 4.2% | 4.48% |
| EPS 2 | 2.94 | 1.48 | 1.3 | 3.13 | 2.82 | 3.761 | 4.115 | 4.39 |
| Distribution rate | 66% | 135% | 162% | 68.7% | 79.8% | 62.6% | 60.8% | 60.7% |
| Net sales 1 | 24,281 | 27,661 | 27,619 | 27,376 | 27,283 | 28,204 | 29,493 | 30,601 |
| EBITDA 1 | 4,602 | 5,240 | 5,092 | 4,726 | 5,020 | 4,962 | 5,248 | 5,501 |
| EBIT 1 | 3,337 | 3,377 | 3,481 | 3,558 | 3,665 | 3,835 | 4,089 | 4,313 |
| Net income 1 | 1,924 | 959 | 881 | 2,021 | 1,825 | 2,367 | 2,606 | 2,787 |
| Net Debt 1 | 10,500 | 10,107 | 10,221 | 8,601 | 8,431 | 8,977 | 8,074 | 7,638 |
| Reference price 2 | 54.59 | 49.23 | 58.68 | 65.12 | 76.78 | 59.50 | 59.50 | 59.50 |
| Nbr of stocks (in thousands) | 650,849 | 626,246 | 641,543 | 643,653 | 640,218 | 643,298 | - | - |
| Announcement Date | 2/23/22 | 2/22/23 | 2/22/24 | 2/26/25 | 2/20/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.24x | 2.77x | 13.8x | 4.08% | 238B | ||
| 18.72x | 2.43x | 14.47x | 3.42% | 76.81B | ||
| 15.82x | 1.67x | 9.42x | 3.95% | 43.52B | ||
| 14.89x | 0.53x | 9.56x | 2.59% | 38.74B | ||
| 19.9x | 3.04x | 12.35x | 3.51% | 33.03B | ||
| 34.27x | 2.97x | 17.31x | 1.08% | 30.36B | ||
| -8.3x | 1.82x | 9.09x | 6.81% | 27.94B | ||
| 62.38x | 9.57x | 39.68x | 1.22% | 27.05B | ||
| 11.12x | 0.37x | 8.41x | 2.64% | 20.95B | ||
| Average | 21.00x | 2.80x | 14.90x | 3.26% | 59.62B | |
| Weighted average by Cap. | 20.33x | 2.70x | 14.20x | 3.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BN Stock
- BSN Stock
- Valuation Danone
Select your edition
All financial news and data tailored to specific country editions
















